Henry Cai's AGIC enters US with pharma buy

The private equity fund, which focuses on investment in fast growing companies in Europe and the US, is backing a pharmaceutical group's Asian expansion.

An AGIC Capital-led consortium has agreed to acquire Ritedose from Olympus Partners, another private equity firm.

Ritedose is a blow-fill-seal maker, a process in which plastic containers are blow-molded, filled with liquid and sealed in one continuous operation under aseptic conditions.

Founded in 1995 in South Carolina, Ritedose also develops, manufactures and sells its own generic portfolio of respiratory pharmaceutical products.

“AGIC is fully committed to providing Ritedose with the resources and regional expertise to support the expansion of the customer base and identify business opportunities in China, and the rest of Asia, Henry Cai, chairman of AGIC, said in a...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222